Juho JALKANEN

Person

Mietoinen, FI

People

Patents Grantslast 30 patents

Information Patent Grant
Method for determining patient's responsiveness to type 1 interfero...
- Patent number 11,421,279
- Issue date Aug 23, 2022
- Faron Pharmaceuticals Oy
- Juho Jalkanen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF DISEASES WITH CLEVER-1 INHIBITION IN COMBINATION WITH...
- Publication number 20230167173
- Publication date Jun 1, 2023
- Faron Pharmaceuticals Oy
- Juho JALKANEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CLEVER-1 AGENTS FOR CONTROLLING THE EXPRESSION OF CELL SURFACE...
- Publication number 20220404366
- Publication date Dec 22, 2022
- Faron Pharmaceuticals Oy
- Maija-Leena HOLLMÉN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR DETERMINING POTENCY OF THERAPEUTIC ANTI-CLEVER-1 ANTIBODY
- Publication number 20220357348
- Publication date Nov 10, 2022
- Faron Pharmaceuticals Oy
- Juho JALKANEN
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF DISEASES WITH SEQUENTIAL ADMINISTRATION OF AN AGENT CA...
- Publication number 20220233644
- Publication date Jul 28, 2022
- Faron Pharmaceuticals Oy
- Juho JALKANEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONTROLLING OF IMMUNE ACTIVATION BY SOLUBLE CLEVER-1
- Publication number 20220227858
- Publication date Jul 21, 2022
- Faron Pharmaceuticals Oy
- Juho JALKANEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR DETERMINING PATIENT'S RESPONSIVENESS TO TYPE 1 INTERFERO...
- Publication number 20200199677
- Publication date Jun 25, 2020
- Faron Pharmaceuticals Oy
- Juho JALKANEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Juho JALKANEN

Person

Patents Grantslast 30 patents

Method for determining patient's responsiveness to type 1 interfero...

Patents Applicationslast 30 patents

TREATMENT OF DISEASES WITH CLEVER-1 INHIBITION IN COMBINATION WITH...

ANTI-CLEVER-1 AGENTS FOR CONTROLLING THE EXPRESSION OF CELL SURFACE...

METHOD FOR DETERMINING POTENCY OF THERAPEUTIC ANTI-CLEVER-1 ANTIBODY

TREATMENT OF DISEASES WITH SEQUENTIAL ADMINISTRATION OF AN AGENT CA...

CONTROLLING OF IMMUNE ACTIVATION BY SOLUBLE CLEVER-1

METHOD FOR DETERMINING PATIENT'S RESPONSIVENESS TO TYPE 1 INTERFERO...